172 related articles for article (PubMed ID: 28708785)
21. The indicative function of Twist2 and E-cadherin in HPV oncogene-induced epithelial-mesenchymal transition of cervical cancer cells.
Liu Y; Qian W; Zhang J; Dong Y; Shi C; Liu Z; Wu S
Oncol Rep; 2015 Feb; 33(2):639-50. PubMed ID: 25420506
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
23. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA SNHG12 modulated by human papillomavirus 16 E6/E7 promotes cervical cancer progression via ERK/Slug pathway.
Lai SY; Guan HM; Liu J; Huang LJ; Hu XL; Chen YH; Wu YH; Wang Y; Yang Q; Zhou JY
J Cell Physiol; 2020 Nov; 235(11):7911-7922. PubMed ID: 31943193
[TBL] [Abstract][Full Text] [Related]
26. EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition.
Gao Q; Liu W; Cai J; Li M; Gao Y; Lin W; Li Z
Hum Pathol; 2014 Feb; 45(2):372-81. PubMed ID: 24439224
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
[TBL] [Abstract][Full Text] [Related]
28. S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.
Tian T; Li X; Hua Z; Ma J; Wu X; Liu Z; Chen H; Cui Z
Oncotarget; 2017 Apr; 8(15):24964-24977. PubMed ID: 28212564
[TBL] [Abstract][Full Text] [Related]
29. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β.
Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C
J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604
[TBL] [Abstract][Full Text] [Related]
30. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
[TBL] [Abstract][Full Text] [Related]
31. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance.
Liu X; Wang D; Liu H; Feng Y; Zhu T; Zhang L; Zhu B; Zhang Y
Cell Cycle; 2014; 13(11):1702-7. PubMed ID: 24675891
[TBL] [Abstract][Full Text] [Related]
33. Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro.
Chang X; Zhang J; Huang C; Pang X; Luo Q; Zhang H; Zhang S
Tumour Biol; 2015 Sep; 36(10):7725-33. PubMed ID: 25935536
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
Bae DS; Cho SB; Kim YJ; Whang JD; Song SY; Park CS; Kim DS; Lee JH
Gynecol Oncol; 2001 Jun; 81(3):341-7. PubMed ID: 11371120
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
Zhang F; Zhou Q
Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.
Hui C; Bai H; Liu J; Lu X; Wang S; Zhang Z; Jin M; Wang Y; Liu Y
Diagn Pathol; 2021 Feb; 16(1):13. PubMed ID: 33608003
[TBL] [Abstract][Full Text] [Related]
37. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
[TBL] [Abstract][Full Text] [Related]
38. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
39. miR-31 functions as an oncogene in cervical cancer.
Zheng W; Liu Z; Zhang W; Hu X
Arch Gynecol Obstet; 2015 Nov; 292(5):1083-9. PubMed ID: 25894339
[TBL] [Abstract][Full Text] [Related]
40. Expression and clinical implications of homeobox gene Six1 in cervical cancer cell lines and cervical epithelial tissues.
Zheng XH; Liang PH; Guo JX; Zheng YR; Han J; Yu LL; Zhou YG; Li L
Int J Gynecol Cancer; 2010 Dec; 20(9):1587-92. PubMed ID: 21370601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
